Heart valve device study halted before it even began
NCT ID NCT04636073
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study was designed to test a new device called Leaflex Performer for people with severe aortic stenosis, a condition where the heart's aortic valve becomes narrowed. The goal was to see if the device could safely improve valve function without major surgery. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.